Skip to main content
Top
Published in: Clinical and Experimental Medicine 3/2018

01-08-2018 | Letter to the Editor

The humoral immunity to epidermal and dermal antigens in psoriasis: a downstream rather than an upstream event

Authors: Leena Chularojanamontri, Chanisada Wongpraparut, Narumol Silpa-Archa, Paleerath Peerapen, Wanida Boonmark, Kanokvalai Kulthanan, Visith Thongboonkerd

Published in: Clinical and Experimental Medicine | Issue 3/2018

Login to get access

Excerpt

The presence of immunoglobulin G (IgG) and complement in upper epidermis of psoriatic skin lesions has been reported for more than 40 years [1, 2]. Recently, a number of antigenic proteins have been observed in psoriatic skin lesions, in association with IgG and complement deposition [3]. Some of them have increased levels in both skin and serum samples of psoriatic patients [4, 5]. However, functional validation and systematic analysis of epidermal antigens that immunoreact to IgG from psoriatic serum are very scarce. Moreover, it is still unclear whether antigen-autoantibody interaction in psoriatic skin lesions is an upstream event (i.e., an early or primary mechanism that subsequently causes disease pathogenesis) or only a downstream phenomenon (i.e., a secondary effect or consequence of psoriatic plaque formation, which can induce secondary humoral immunity to the exposed epidermal antigens). Hence, this hazy mechanism of antigen recognition in psoriatic skin should be elucidated. …
Literature
1.
go back to reference Jablonska S, Chorzelski TP, Jarzabek-Chorzelska M, Beutner EH. Studies in immunodermatology. VII. Four-compartment system studies of IgG in stratum corneum and of stratum corneum antigen in biopsies of psoriasis and control dermatoses. Int Arch Allergy Appl Immunol. 1975;48:324–40.CrossRefPubMed Jablonska S, Chorzelski TP, Jarzabek-Chorzelska M, Beutner EH. Studies in immunodermatology. VII. Four-compartment system studies of IgG in stratum corneum and of stratum corneum antigen in biopsies of psoriasis and control dermatoses. Int Arch Allergy Appl Immunol. 1975;48:324–40.CrossRefPubMed
2.
go back to reference Takematsu H, Tagami H. Generation of terminal complement complexes in psoriatic lesional skin. Dermatology. 1992;185:246–50.CrossRefPubMed Takematsu H, Tagami H. Generation of terminal complement complexes in psoriatic lesional skin. Dermatology. 1992;185:246–50.CrossRefPubMed
3.
go back to reference El Rachkidy RG, Young HS, Griffiths CE, Camp RD. Humoral autoimmune responses to the squamous cell carcinoma antigen protein family in psoriasis. J Investig Dermatol. 2008;128:2219–24.CrossRefPubMed El Rachkidy RG, Young HS, Griffiths CE, Camp RD. Humoral autoimmune responses to the squamous cell carcinoma antigen protein family in psoriasis. J Investig Dermatol. 2008;128:2219–24.CrossRefPubMed
4.
go back to reference Takeda A, Higuchi D, Takahashi T, Ogo M, Baciu P, Goetinck PF, et al. Overexpression of serpin squamous cell carcinoma antigens in psoriatic skin. J Investig Dermatol. 2002;118:147–54.CrossRefPubMed Takeda A, Higuchi D, Takahashi T, Ogo M, Baciu P, Goetinck PF, et al. Overexpression of serpin squamous cell carcinoma antigens in psoriatic skin. J Investig Dermatol. 2002;118:147–54.CrossRefPubMed
5.
go back to reference Watanabe Y, Yamaguchi Y, Komitsu N, Ohta S, Azuma Y, Izuhara K, et al. Elevation of serum squamous cell carcinoma antigen 2 in patients with psoriasis: associations with disease severity and response to the treatment. Br J Dermatol. 2016;174:1327–36.CrossRefPubMed Watanabe Y, Yamaguchi Y, Komitsu N, Ohta S, Azuma Y, Izuhara K, et al. Elevation of serum squamous cell carcinoma antigen 2 in patients with psoriasis: associations with disease severity and response to the treatment. Br J Dermatol. 2016;174:1327–36.CrossRefPubMed
6.
go back to reference Chiricozzi A, Suarez-Farinas M, Fuentes-Duculan J, Cueto I, Li K, Tian S, et al. Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris. Br J Dermatol. 2016;174:136–45.CrossRefPubMed Chiricozzi A, Suarez-Farinas M, Fuentes-Duculan J, Cueto I, Li K, Tian S, et al. Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris. Br J Dermatol. 2016;174:136–45.CrossRefPubMed
7.
go back to reference Hijnen D, Knol EF, Gent YY, Giovannone B, Beijn SJ, Kupper TS, et al. CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-gamma, IL-13, IL-17, and IL-22. J Investig Dermatol. 2013;133:973–9.CrossRefPubMed Hijnen D, Knol EF, Gent YY, Giovannone B, Beijn SJ, Kupper TS, et al. CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-gamma, IL-13, IL-17, and IL-22. J Investig Dermatol. 2013;133:973–9.CrossRefPubMed
8.
go back to reference Ruano J, Suarez-Farinas M, Shemer A, Oliva M, Guttman-Yassky E, Krueger JG. Molecular and cellular profiling of scalp psoriasis reveals differences and similarities compared to skin psoriasis. PLoS ONE. 2016;11:e0148450.CrossRefPubMedPubMedCentral Ruano J, Suarez-Farinas M, Shemer A, Oliva M, Guttman-Yassky E, Krueger JG. Molecular and cellular profiling of scalp psoriasis reveals differences and similarities compared to skin psoriasis. PLoS ONE. 2016;11:e0148450.CrossRefPubMedPubMedCentral
9.
go back to reference Seifert O, Soderman J, Skarstedt M, Dienus O, Matussek A. Increased expression of the Wnt signalling inhibitor Dkk-1 in non-lesional skin and peripheral blood mononuclear cells of patients with plaque psoriasis. Acta Derm Venereol. 2015;95:407–10.CrossRefPubMed Seifert O, Soderman J, Skarstedt M, Dienus O, Matussek A. Increased expression of the Wnt signalling inhibitor Dkk-1 in non-lesional skin and peripheral blood mononuclear cells of patients with plaque psoriasis. Acta Derm Venereol. 2015;95:407–10.CrossRefPubMed
10.
go back to reference Cabrijan L, Batinac T, Lenkovic M, Gruber F. The distinction between lesional and non-lesional skin in psoriasis vulgaris through expression of adhesion molecules ICAM-1 and VCAM-1. Med Hypotheses. 2009;72:327–9.CrossRefPubMed Cabrijan L, Batinac T, Lenkovic M, Gruber F. The distinction between lesional and non-lesional skin in psoriasis vulgaris through expression of adhesion molecules ICAM-1 and VCAM-1. Med Hypotheses. 2009;72:327–9.CrossRefPubMed
11.
go back to reference Amin MM, Azim ZA. Immunohistochemical study of osteopontin, Ki-67, and CD34 of psoriasis in Mansoura, Egypt. Indian J Pathol Microbiol. 2012;55:56–60.CrossRefPubMed Amin MM, Azim ZA. Immunohistochemical study of osteopontin, Ki-67, and CD34 of psoriasis in Mansoura, Egypt. Indian J Pathol Microbiol. 2012;55:56–60.CrossRefPubMed
12.
go back to reference Suihko C, Serup J. Fluorescent fibre-optic confocal imaging of lesional and non-lesional psoriatic skin compared with normal skin in vivo. Skin Res Technol. 2012;18:397–404.CrossRefPubMed Suihko C, Serup J. Fluorescent fibre-optic confocal imaging of lesional and non-lesional psoriatic skin compared with normal skin in vivo. Skin Res Technol. 2012;18:397–404.CrossRefPubMed
Metadata
Title
The humoral immunity to epidermal and dermal antigens in psoriasis: a downstream rather than an upstream event
Authors
Leena Chularojanamontri
Chanisada Wongpraparut
Narumol Silpa-Archa
Paleerath Peerapen
Wanida Boonmark
Kanokvalai Kulthanan
Visith Thongboonkerd
Publication date
01-08-2018
Publisher
Springer International Publishing
Published in
Clinical and Experimental Medicine / Issue 3/2018
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-018-0503-8

Other articles of this Issue 3/2018

Clinical and Experimental Medicine 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.